Glenmark Pharmaceuticals Inc., USA to launch Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial

Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the upcoming launch1 of Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial. Glenmark's Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial is bioequivalent and therapeutically equivalent to the reference listed drug, Leucovorin Calcium for Injection, 350 mg/vial, of Hospira, Inc. [NDA 008107]. Glenmark will begin distribution in December 2025.

According to IQVIA® sales data for the 12-month period ending October 2025, the Leucovorin Calcium for Injection, 350 mg/vial market2 achieved annual sales of approximately $16.8 million*.

Commenting on the launch, Marc Kikuchi, President & Business Head, North America said, "We are pleased to announce the upcoming launch of Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial, further expanding our portfolio of products within the institutional channel, while also strengthening our commitment to bring to market quality and affordable alternatives for patients."

Glenmark's Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial is only approved for the indication(s) listed in Glenmark's approved label.

Market includes brand and all available therapeutic equivalents. Note: IQVIA® data obtained by Glenmark is only available for all approved RLD indications. Glenmark's product is only approved for the indications listed in Glenmark's approved label and is not marketed for all RLD indications.

Shares of Glenmark Pharmaceuticals Limited was last trading in BSE at Rs. 1952.90 as compared to the previous close of Rs. 1938.35. The total number of shares traded during the day was 6095 in over 857 trades.

The stock hit an intraday high of Rs. 1959.25 and intraday low of 1925.25. The net turnover during the day was Rs. 11873000.00.

*IQVIA® National Sales Perspectives: Retail & Non-Retail, October 2025

Source : Equity Bulls

Keywords

GlenmarkPharmaceuticals INE935A01035 LeucovorinCalcium Injection